VENUNGOPAL, P., BALAKRISHNAN, K., SRIRAM, D. K. and GEORGE, M. (2022) “INCLISIRAN (LEQVIO): A FIRST-IN-CLASS SMALL INTERFERING RNA THERAPEUTIC DRUG APPROVED BY FDA FOR TREATING PRIMARY HYPERCHOLESTEROLEMIA OR DYSLIPIDEMIA”, Asian Journal of Pharmaceutical and Clinical Research, 15(12), pp. 42–46. doi: 10.22159/ajpcr.2022.v15i12.46054.